Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Alere Inc    ALR

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Alere Inc : Alere Inc. Schedules Conference Call for 8:30 a.m. ET February 8, 2012 to Discuss Fourth Quarter 2011 Results

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/01/2012 | 09:20pm CEST

WALTHAM, Mass., Feb. 1, 2012 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced that it will release its fourth quarter 2011 earnings on Wednesday, February 8, 2012. The Company will also host a conference call beginning at 8:30 a.m. (Eastern Time) on that date to discuss these results and other corporate matters. During the conference call, the Company will discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously.

The conference call may be accessed by dialing (800) 860-2442 (domestic) or (412) 858-4600 (international) and asking for Alere Inc. A webcast of the call can also be accessed via the Alere website at www.alere.com/investors, or directly through the following link: http://www.videonewswire.com/event.

A replay will be available approximately four hours after the conclusion of the call and will remain available for a period of seven days following the call. The replay may be accessed by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international) and entering replay code 10009812. The replay will also be available via online webcast at http://www.videonewswire.com/event or via the Alere website at www.alere.com/investors for a period of 60 days following the call.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, toxicology and women's health. Alere is headquartered in Waltham, Massachusetts.

For additional information on Alere, please visit www.alere.com.

SOURCE Alere Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ALERE INC
05/24 ALERE : Announces Update on Form 10-K and Provides Preliminary Unaudited Financi..
05/22 ALERE INC. : Results of Operations and Financial Condition, Financial Statements..
05/22 ALERE : Announces Update on Form 10-K and Provides Preliminary Unaudited Financi..
05/08 ALERE : Announces Successful Completion of Consent Solicitations for Alere Inc.&..
05/08 ALERE INC. : Announces Successful Completion of Consent Solicitations for Alere ..
05/04 ALERE : Launches the Alere Malaria Ag P.f, the First-Ever Rapid Test to Screen M..
05/04 ALERE : Announces Modifications of Consent Solicitations for Alere Inc.’s ..
05/04 ALERE INC. : Announces Modifications of Consent Solicitations for Alere Inc. :'s..
05/01 ALERE INC. : Other Events (form 8-K)
05/01 ALERE : Announces Commencement of Consent Solicitations for Alere Inc.’s N..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
05/23DJFirms Persuade SEC on Profit Metric -- WSJ
05/22DJCompanies Are Winning the Battle Over Adjusted Earnings
05/17 PHILIPS CEO : uptake of connected care products progressing slowly
05/15DJMARKET SNAPSHOT : Stock Market Sets Fresh Records As Oil Rallies
05/15 Thermo Fisher to buy Patheon for $5.2 billion to expand biopharma services
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
05/24 RISK ARBITRAGE TODAY : Why Westar Energy's Deal Is Not Dead
05/22 Alere Q4 top line off 3%; loss/share of $1.41; shares up 2% on resolution acc..
05/17 Tracking David Einhorn's Portfolio - Q1 2017 Update
05/16 Top Merger Stocks Held By Fund Managers (Mid-Q2 2017 Edition)
05/15 Greenlight cuts position in Apple, adds to GM